Lyra Therapeutics, Inc. (LYRA)
1.49
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 13:57
Lyra Therapeutics EPS Diluted (Quarterly) : -3.385 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.984M |
| Revenue (Quarterly) | 0.025M |
| Total Expenses (Quarterly) | 6.009M |
| Enterprise Value | 11.30M |
| Gross Profit Margin (Quarterly) | -300.0% |
| Profit Margin (Quarterly) | -23.94K% |
| Earnings Yield | -1.17K% |
| Normalized Earnings Yield | -1095.54 |